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Abstract 
Background: Fournier’s gangrene (FG) is a rare, rapidly progressive, necrotizing fasciitis of the external genitalia and 
perineum, leading to soft-tissue necrosis. Despite antibiotics and aggressive debridement, the mortality rate of FG 
remains high. This study describes our experiences in the management of FG and identifies prognostic factors.
Methods: This was a descriptive retrospective study of patients with FG treated at Bugando Medical Centre between 
November 2006 and April 2014.
Results: A total of 84 patients (M:F = 41:1) were studied. The median age was 34 years (range 15–76 years). The most 
common predisposing factor was diabetes mellitus (16.7 %). Nine (11.3 %) patients were HIV positive. Bacterial culture 
results were obtained in only 46 (54.8 %) patients. Of these, 38(82.6 %) had polymicrobial bacterial growth while 8 
(17.4 %) had monomicrobial bacterial growth. Escherichia coli (28.3 %) were the most frequent bacterial organism iso-
lated. All the microorganisms isolated showed high resistance to commonly used antibiotics except for Meropenem 
and imipenem, which were 100 % sensitive each respectively. All patients were treated with a common approach 
of resuscitation, broad-spectrum antibiotics, and wide surgical excision. The median length of hospital stay (LOS) 
was 28 days and mortality rate was 28.6 %. Systemic inflammatory response syndrome and diabetes mellitus were 
significantly associated with prolonged LOS (p < 0.001), whereas advancing age (>60 years), late presentation (>48 h), 
systemic inflammatory response syndrome on admission, diabetes mellitus, extension of infection to the abdominal 
wall, FG severity score >9 and HIV infection with CD4 count <200 μl/cells) were independent predictors of mortality 
(p < 0.001).
Conclusion: Fournier’s gangrene remains a very severe disease with high mortality rates. Early recognition of infec-
tion associated with invasive and aggressive treatment is essential for attempting to reduce mortality rates associated 
with this disease in our setting.
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Background
Fournier’s gangrene is a rare and often fulminant 
necrotizing fasciitis of the perineum, perianal and geni-
tal regions, which may extend up to the abdominal wall 
between the fascial planes [1]. The condition was first 
described as a disease of young adults of unknown cause 
by Fournier in 1888 [2]. It is secondary to polymicrobial 
infection by aerobic and anaerobic bacteria with a syn-
ergistic action [3–6]. Fournier’s gangrene commonly 
affects men but does not spare women who constitute 
about 10 % and also afflicts children. It occurs commonly 
among those in their 5th and 6th decade [7].
The cause of infection is identifiable in 95  % of cases, 
mainly arising from anorectal, genito-urinary and cuta-
neous sources [8]. Predisposing factors include diabetes 
mellitus, local trauma, urine leakage, perirectal or per-
ineal surgery, ex-tension of periurethral, anal infection, 
anorectal abscess, genitourinary infection, alcoholism, 
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immunosuppression and renal or hepatic disease [4, 7, 
9, 10]. Diagnosis is based on clinical signs and physical 
examination. Radiological methods may help to delineate 
the extent of the disease but false negatives may happen. 
Several reports tried to evaluate the usefulness of diverse 
scoring systems. Fournier’s Gangrene Severity Index 
(FGSI) has become a standard for researchers, being rou-
tinely published in FG literature and is considered as a 
good predicting tool [11–14].
Despite a multidisciplinary approach that includes 
broad-spectrum antibiotics, radical surgical debride-
ment and hemodynamic support in an intensive care 
unit (ICU), mortality rates are still very high and can 
be as high as 88  % [15, 16]. Early diagnosis, aggressive 
resuscitation of the patient, administration of broad-
spectrum antibiotics and aggressive radical surgical 
debridement(s), are the key of successful treatment [17]. 
A sudden increase in the number of patients with Fourni-
er’s gangrene at Bugando Medical Centre (in northwest-
ern Tanzania) in recent years and lack of published data 
on this subject prompted the authors to analyze this 
problem. This study was conducted in our setting to 
describe our experiences in the management of Fourni-
er’s gangrene and to identify predictors of outcome 
among these patients.
Methods
This was a descriptive retrospective study of patients with 
Fournier’s gangrene carried out at Bugando Medical Cen-
tre (BMC) in northwestern Tanzania between November 
2006 and April 2014. Bugando Medical Centre is located 
in Mwanza city along the shore of Lake Victoria in the 
northwestern part of Tanzania. It is a tertiary care and 
teaching hospital for the Catholic University of Health 
and Allied Sciences-Bugando (CUHAS-Bugando) and 
other paramedics and has a bed capacity of 1000. BMC 
is one of the four largest referral hospitals in the country 
and serves as a referral centre for tertiary specialist care 
for a catchment population of approximately 13 million 
people from neighboring regions.
All patients who were diagnosed and managed for 
Fournier’s gangrene during the study period were 
included in the study. Patients who had incomplete data 
were excluded from the study. The diagnosis of Fourni-
er’s gangrene was based on history and clinical exami-
nation. The details of patients were retrieved from the 
patient files kept in the medical record department, the 
surgical wards, operating theatre and laboratories. Data 
collected included age, gender, risk factors, etiology, 
clinical signs and symptoms, clinical parameters (heart 
rate, temperature, respiratory rate and blood pressure), 
laboratory findings (serum sodium, potassium, creati-
nine and bicarbonate, hematocrit and leukocyte count), 
duration of symptoms before admission and number of 
surgical debridement. The severity of Fournier’s gangrene 
on admission was assessed using the Fournier’s gangrene 
severity index (FGSI) score [12, 13]. We calculated FGSI 
from clinical (temperature, heart and respiratory rate) 
and laboratory parameters (serum sodium, potassium, 
creatinine and bicarbonate, haematocrit and leukocyte 
count) obtained on admission, as suggested by Laor et al. 
[18]. Each parameter is given 04 points, and FGSI is cal-
culated by summing up the points of each parameter. The 
cutoff point is 9 so that when FGSI is >9, the probability 
of death is 75 % and when it is <9, the probability of sur-
vival is 78 %.
Patients were resuscitated where necessary with intra-
venous fluids, antibiotics (metronidazole, ceftriaxone and 
gentamicin), analgesics, and anti-tetanus prophylaxis, 
blood transfusions were also given. Investigations carried 
out included packed cell volume, urinalysis, blood sugar 
and chemistry, wound swab and biopsy for microbial cul-
ture, and HIV screening. Wound debridement was done 
for all patients (some more than once) under general or 
spinal anesthesia. The definitive management was done 
when the wound became clean with healthy granulation. 
The definitive management took the form of healing by 
secondary intention, by secondary closure, skin grafting, 
and skin flap rotation.
Mortality was defined as disease-related death dur-
ing the hospital stay and the length of hospital stay was 
measured in days. The prognostic variables used in the 
outcome analysis were the patient’s age, gender, infec-
tion source, existing predisposing factors, the interval 
between the onset of symptoms and hospital admission, 
clinical findings, laboratory results, number of surgical 
debridement, whether or not colostomy was performed, 
occurrence of sepsis and FGSI.
Definition of terms
Systemic inflammatory response syndrome was defined as 
the presence of two or more of the following, tempera-
ture >38  °C or <36  °C, tachycardia >90 beats/min, res-
piratory rate >20 breaths/min and white blood cell count 
>12 × 109/L or <4 × 109/L.
Sepsis was defined as bacterial infection of blood 
stream or body tissue.
Leukocytosis was defined as a white blood cell count of 
10,000/mm3 or more.
Anemia was defined as hemoglobin levels <10 g/dl.
Statistical data analysis
Statistical data analysis was performed using SPSS com-
puter software version 17.0 (SPSS, Inc., Chicago, IL, 
USA). Data were summarized in the form of proportions 
and frequency tables for categorical variables. Continuous 
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variables were summarized using median (+IQR) and 
ranges. The correlation of prognostic (independent) vari-
ables and outcome variables (mortality and length of hos-
pital stay were studied by univariate analysis using Chi 
squared test and Fisher’s exact probability test. Statisti-
cally significant variables were entered into multivariate 
regression analysis using logistic regression. P values were 
reported as the result of two-tailed testing and P values 
less than 0.05 were considered as statistically significant.
Ethical consideration
The study was performed according to the declaration of 
Helsinki and approved by the CUHAS-Bugando/BMC 
joint institutional ethic review committee before the 
commencement of the study. This research being a ret-
rospective study where patient’s files kept in the medical 
record department, the surgical wards, operating theatre 
and laboratories have been used to gather the informa-
tion, no written informed consent for participation in 
the study was obtained from participants or, where par-
ticipants are children, a parent or guardian. The confi-
dentiality of the patient was maintained at all time of the 
study and only file numbers were used instead of patient’s 
names.
Results
A total of 88 patients were seen over a period of study 
with four patients excluded from the study on account of 
incomplete data, leaving 84 patients for the final analy-
sis. There were 82 (97.6  %) males and 2 (2.4  %) females 
with a male to female ratio of 41: 1. The age of patients at 
presentation ranged from 15 to 76 years with a median of 
34 years (+IQR of 32 to 41 years). The modal age group 
was 31–40 years accounting for 58.3 % of cases (Fig. 1). 
Most of patients, 68 (81.0  %) had either primary or no 
formal education and more than 80  % of them were 
unemployed. The majority of patients, 72 (85.7 %) came 
from the rural areas located a considerable distance from 
the study area and more than ninety percent of them had 
no identifiable health insurance.
Predisposing factors for Fournier’s gangrene were 
identified in 69 (82.1 %) patients of which diabetes mel-
litus was the leading predisposing factor associated 
with Fournier’s gangrene and accounted for 14 (16.7  %) 
patients. The predisposing factors for Fournier’s gan-
grene were not identified in 17.9 % of cases (Table 1).
The scrotum was the most frequent anatomical loca-
tion involved accounting for 78.6 % of cases. Other ana-
tomical location and extent are shown in Table 2.
The duration of symptoms before admission ranged from 
1 to 18 days with a median of 4 days (+IQR of 2–8 days). 
The majority of patients, 64 (76.2 %) sought medical atten-
tion after more than 48  h of the onset of symptoms. The 
onset of symptoms was insidious in 48 (57.1 %) patients and 
abrupt in 36 (42.9 %) patients. Of the 84 patients, 62 (73.8 %) 
presented with established ulcers of the involved area, 12 
Fig. 1 Distribution of patients according to the age group
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(14.3  %) had established gangrene while the remaining 10 
(11.9 %) presented with cellulitis, which later progressed to 
scrotal gangrene or resolved with treatment. All patients 
presented with fever, pain and discharge of sero-purulent 
material from the site. They also had swelling, redness, ten-
derness, and black dermal necrosis of the skin.
Hematological investigations revealed leukocytosis in 
all the patients (100 %), elevated ESR in 76 (90.5 %) and 
anemia (hemoglobin <10  g/dL) in 80 (95.2  %) patients. 
Out of 80 patients tested for HIV infection, nine (11.3 %) 
were HIV positive. Of the HIV positive patients, three 
(33.3  %) patients were known cases on ant-retroviral 
therapy (ARV) and the remaining 6 (66.7  %) patients 
were, CD 4+ count among HIV positive patients was 
available in only 5 patients and ranged from 113 to 678 
cells/μl with a median of 236 cells/μl (+IQR of 232–240 
cells/μl).
In this study, aerobic bacterial culture results were 
obtained in only 46 (54.8 %) patients. Of these, 38(82.6 %) 
had polymicrobial bacterial growth while 8 (17.4  %) 
had monomicrobial bacterial growth. Escherichia coli 
(28.3  %) and Staphylococcus aureus (17.4  %) were the 
most frequent bacterial organisms isolated (Table  3). 
Anaerobic cultures were not done due to lack of facility 
to perform this test. Antibacterial susceptibility testing 
revealed that most of pathogens isolates had multiple 
resistant to almost all tested antibiotics (such as ampi-
cillin, augumentin, cotrimoxazole, tetracycline, penicil-
lin, gentamicin, erythromycin, oxacillin etc.) except for 
Meropenem and imipenem, which were 100 % sensitive 
each respectively.
Before surgery, all patients underwent aggressive fluid 
resuscitation and were treated mostly with parenteral 
broad-spectrum triple antimicrobial agents, using a 
third-generation cephalosporin, an aminoglycoside and 
metronidazole and received hemodynamic support when 
required. Meropenem and imipenem, which were 100 % 
sensitive were given to only few patients who managed 
to purchase. Mechanical ventilation, continuous moni-
toring, and inotropic support were applied when nec-
essary in patients with cardiopulmonary failure due to 
sepsis. All patients underwent radical surgical debride-
ment, ranging from 1 to 8 procedures, with a median of 
3 (+IQR of 1 to 5). Debridement consisted of excision 
of all necrotic tissue, cleansing with hydrogen peroxide, 
then saline and packed with dressings soaked in povi-
done-iodine. Orchidectomy was carried out unilaterally 
for gangrenous testes in 3 (3.6 %) patients. There were no 
adjunct surgeries such as suprapubic cystostomy, colos-
tomy or penectomy. After the initial surgery, the wound 
was closely monitored, adequate nutrition was ensured 
to support wound healing and early enteral feeding was 
considered. The patients underwent repeated debride-
ments as necessary and further necrotic tissues were 
debrided when needed under local or no anesthesia. 
Table 1 Distribution of  patients according to  predispos-
ing/etiological factors
Predisposing/etiological factors Number of patients Percentages
Diabetes mellitus 14 16.7
Peri-anal abscess 11 13.1
HIV/AIDS 9 9.5
Post-inguinoscrotal herniorrhaphy 8 8.3
Perineal/scrotal trauma 8 8.3
Thrombosed haemorrhoids 7 8.3
Post-hydrocelectomy 5 6.0
Urethral stricture with watering 
cane perineum
2 2.4
Benign prostatic hyperplasia 2 2.4
Post-penile amputation 2 2.4
Urinary bladder injury with 
extravasation of urine
1 1.2
Predisposing factor not identified 15 17.9











Lower anterior abdominal wall 1 1.2
Table 3 Distribution of  patients according to  the type 
of micro-organisms isolated
Micro-organisms isolated Frequency Percentages
Escherichia coli 13 28.3
Staphylococcus aureus 8 17.4
Klebsiella pneumonia 7 15.2
ß-hemolytic streptococcus 6 13.0
Acinetobacter spp 4 8.7
Pseudomonas aeruginosa 2 4.3
Proteus vulgaris 2 4.3
Other rare spp 4 8.7
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Closure of wounds was commenced as soon as healthy, 
viable tissue allowed re-approximation. The majority of 
the patients, 65 (77.4 %) had wound closure by second-
ary closure. Other patients had their wound closed by 
skin grafting and flap rotation in 14 (16.7 %) and 5 (5.9 %) 
patients respectively.
The overall length of hospital stay (LOS) ranged from 
8 to 56  days with a median of 28  days (+IQR of 26 to 
32 days). The median LOS for non-survivors was 7 days 
(range 1–16 days). Factors predicting the length of hos-
pital stay in univariate analysis were systemic inflam-
matory response syndrome on admission (OR  =  2.4, 
95  %CI (1.1–6.3), p  =  0.034), late presentation >48  h 
(OR = 4.8, 95 % CI (3.2–6.9), p = 0.016), HIV positiv-
ity (OR  =  5.2, 95  % CI (2.8–9.0), p  =  0.003) and dia-
betes mellitus (OR = 2.1, 95 % CI (1.0–6.7), p = 0.011). 
According to multivariate logistic regression analysis, 
systemic inflammatory response syndrome [odds ratio 
(OR)  =  3.9, 95  % confidence interval (CI): 1.5–8.5, 
p  =  0.002) and diabetes mellitus (OR  =  3.0, 95  % CI: 
2.1–5.9, p  =  0.044) were the main predictors of the 
length of hospital stay.
In this study, twenty-four patients died giving a mor-
tality rate of 28.6  %. Univariate analysis revealed high 
mortality rates in the following conditions; advancing age 
>60 years (p = 0.003), hospital admission later than 48 h 
of onset of symptoms (p = 0.012), systemic inflammatory 
response syndrome on admission (p  =  0.001), diabetes 
mellitus (p = 0.002), HIV positivity (p = 0.005), low CD 
4 count (<200 μl/cells) and FGSI >9 (p = 0.003). Accord-
ing to multivariate logistic regression analysis; advanc-
ing age >60  years (Odds ratio =  2.4, 95  % CI (1.7–4.6), 
p  =  0.002), late presentation >48  h (Odds ratio  =  3.9, 
95  % CI (2.2–9.4), p  =  0.000), systemic inflammatory 
response syndrome on admission (Odds ratio  =  7.3, 
95  %CI (2.5–9.7), p  =  0.016), diabetes mellitus (Odds 
ratio  =  2.2, 95  % CI (1.7–5.9), p  =  0.010), extension 
of infection to the abdominal wall (Odds ratio  =  6.7, 
95 %CI (3.8–9.0), low CD 4 count (<200 μl/cells) (Odds 
ratio = 4.9, 95 % (2.1–8.7), p = 0.021) and FGSI >9 (Odds 
ratio = 3.7, 95 % CI (2.8–5.6), p = 0.004).
Discussion
Fournier’s gangrene is an acute, rapidly progressive and 
potentially fatal, infective necrotizing fasciitis affecting 
the external genitalia, perineal or perianal regions fre-
quently due to a synergistic polymicrobial infection. It 
affects both sexes and all ages [1, 3–7]. In this study, the 
male predominance is in keeping with previous observa-
tions reported in studies done elsewhere [3–7, 15, 17, 18]. 
We could not find the reason for this gender distribution.
In this review, the median age of patients at presenta-
tion was 34 years, which is lower than the age reported in 
the literature [7, 16–18]. A study performed in Egypt by 
Ghnnam [19] reported the mean age of patients at diag-
nosis to be 51 years (21–72 years). Other studies reported 
older age at presentation [20–22]. We could not establish 
the reason for this age difference.
Fournier’s gangrene has been reported to be more 
prevalent in people with low socio-economic status [19]. 
This observation is reflected in our study where most of 
patients had either primary or no formal education and 
more than 75 % of them were unemployed. The majority 
of patients in the present study came from the rural areas 
located a considerable distance from the study area and 
more than 90 % of them had no identifiable health insur-
ance. Similar observation was reported by others [19, 21, 
22]. This observation has an implication on accessibility 
to health care facilities and awareness of the disease.
In keeping with other studies reported elsewhere [23–
25], Diabetes mellitus was the most reported co-morbid 
disease associated with this pathology. Some authors 
estimate the prevalence of Diabetes mellitus among 
Fournier’s gangrene patients between 50 and 70 percent 
[23, 25]. Diabetes mellitus has been reported in literature 
as a risk factor for Fournier’s gangrene and associated 
with a more progressive and fatal outcome resulting from 
decreased phagocytic and intracellular bactericidal activ-
ity and neutrophil dysfunction [24],
In the present study, the scrotum was the most fre-
quent anatomical site involved in more than three quar-
ter percent of patients. Similar finding was also reported 
by Ayumba [26] in Kenya. Other studies reported ano-
rectal region as the most common site involved [3, 7, 17, 
19–21].
It has been reported that the interval between the onset 
of symptoms and initiation of treatment is a better pre-
dictor of outcome. In the present study most of patients 
presented late more than 48  h from the start of symp-
toms. This is in agreement with other studies in most 
developing countries [3, 17, 26]. Late presentation in our 
study may be attributed to lack of accessibility to health 
care facilities as more than eighty-five percent of patients 
came from the rural areas located a considerable distance 
from the study area and more than ninety percent of 
them had no identifiable health insurance.
The prevalence of HIV infection among patients with 
Fournier’s gangrene in the present study was 11.3  % 
that is significantly higher than 6.5 % [27] in the general 
population in Tanzania. The exact reason for the high 
prevalence of HIV infection in our patients is not known 
although it is possible that HIV positive patients have an 
increased risk of Fournier’s gangrene and are therefore 
overrepresented.
Various bacterial organisms both aerobes and 
anaerobes have been identified as agents that acts 
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synergistically in causing the disease [5]. In our series, 
polymicrobial organisms were identified in more than 
eighty percent of cases. Most authorities believe the pol-
ymicrobial nature of Fournier gangrene is necessary to 
create the synergy of enzyme production that promotes 
rapid multiplication and spread of the infection [4, 7, 9]. 
The microbiological results of our study are similar to the 
literature, with Escherichia coli being the most prevalent 
organism [5, 9]. This centre has no facilities for anaero-
bic culture which probably accounted for the growth of 
only Escherichia coli. All the microorganisms isolated in 
this study showed multi-resistance to commonly used 
antibiotics except for Meropenem and imipenem which 
were all 100  % sensitive respectively. Unfortunately, 
these antibiotics are expensive for the level of economi-
cal development which subsists in this part of the devel-
oping world. The finding of polymicrobial infection and 
multiple resistant to commonly used antibiotics calls for 
immediately surgical intervention. Antibiotic susceptibil-
ity testing remains of paramount importance in the man-
agement of Fournier’s gangrene.
The main stays of treatment of Fournier’s gangrene are 
resuscitation, broad spectrum intravenous antibiotics 
and radical debridement [8, 28], same principles were fol-
lowed in our centre. The role of hyperbaric oxygen and 
immuno-globulin has been well explored [29, 30] but it is 
not available in our centre as in most parts of the devel-
oping tropical African countries [29, 30] but instead all 
the patients had twice daily warm sitz bath after the ini-
tial debridement with a very good response.
The corporal bodies and testes are rarely affected 
because they have independent blood supplies that origi-
nate intra-abdominally. However, severe infections may 
penetrate the urogenital diaphragm and the perivesicle 
space and gain entry into the inguinal canal via the inter-
nal and external fascia of the spermatic cord [4, 28]. In 
this study, only three patients had orchidectomy as a 
result of gangrenous testis.
Some authors advocate suprapubic cystostomy and 
diverting colostomy to prevent wound contamination 
[28]. In the present study, there were no adjunct surger-
ies such as suprapubic cystostomy, diverting colostomy 
or penectomy. The two patients with urethral stricture 
with watering cane perineum identified in this study were 
managed by direct vision urethrotomy (DVU).
The length of hospital stay is an important meas-
ure of morbidity in which estimates of length of hospi-
tal stay are important for financial matters and accurate 
early estimates so as to facilitate better financial plan-
ning by the payers since it takes long for the Fournier’s 
gangrene to heal so increasing the costs as well as seen 
in other studies as well [14–16]. In this study, the over-
all median length of hospital stay was 28  days, a figure 
which is higher than that reported in other studies [16, 
17, 28]. Prolonged length of hospital stay in our study was 
observed in patients with associated systemic inflamma-
tory response syndrome and diabetes mellitus.
Early diagnosis, antimicrobial treatment with broad-
spectrum combinations followed by prompt surgi-
cal debridement is the recommended management of 
Fournier’s gangrene [3, 7]. Even with this sequence of 
treatment approaches, mortality is high, 4–67  % [1, 
19, 20, 23]. The high mortality reflects both the aggres-
sive nature of the infection and the destructive effects 
of accompanying predisposing factors. In this study, 
the mortality rate was 28.6  % which is higher than that 
reported in other studies [10, 21, 28]. High mortality 
rate in the present study was attributed to advancing age 
(>60 years), late presentation (>48 h), systemic inflamma-
tory response syndrome (SIRS), on admission, diabetes 
mellitus, extension of infection to the abdominal wall, 
Fournier’s gangrene severity score (FGSI) >9 and HIV 
infection with low CD4 count (<200 μl/cells). Address-
ing these factors responsible for the high mortality in our 
patients is mandatory to be able to reduce mortality asso-
ciated with Fournier’s gangrene.
The major limitation of the study was poor documen-
tation of medical findings and poor record keeping in 
view of the retrospective nature of the study. This might 
have introduced some bias in our findings. Microbiologi-
cal analysis was only performed in less than one half of 
the patients. Therefore, the bacterial spectrum reported 
in this study might not representative. Failure to perform 
blood and anaerobic cultures were also a major limitation 
in this study. We however believe that despite of these 
limitations, some of the critical issues in Fournier’s gan-
grene have been well expounded by this study,
Conclusion
Fournier’s gangrene remains a very severe disease in this 
part of Tanzania and is associated with a high mortality 
rate. Diabetes mellitus was the leading major illness asso-
ciated with Fournier’s gangrene. The advanced age, late 
presentation, systemic inflammatory response syndrome 
on admission, diabetes mellitus, extension of infection 
to the abdominal wall, high Fournier’s gangrene severity 
score (>9) and HIV infection with low CD4 count (<200 
μl/cells) were the main prognostic factors of mortality. 
Early recognition of infection associated with invasive 
and aggressive treatment is essential for attempting to 
reduce these prognostic factors. Antibiotic susceptibility 
testing remains of paramount importance in the manage-
ment of this condition.
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